Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Argentina In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

Published by Mordor Intelligence Pvt Ltd Product code 391019
Published Content info 80 Pages
Delivery time: 2-3 business days
Back to Top
Argentina In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)
Published: June 1, 2020 Content info: 80 Pages

In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body, to provide information for screening, diagnosis, or treatment monitoring purposes. The rising prevalence of chronic diseases in Italy has been the primary driver for the growth of this market.

This rising prevalence has increased the demand for early and effective diagnostic tests. The use of point-of-care (POC) diagnostics has also increased over the past few decades. Moreover, increasing awareness and acceptance of personalized medicine and companion diagnostics have helped the market growth.

However, reimbursement policies and stringent regulatory guidelines are some of the restraining factors in the market studied.

Key Market Trends

Application in Cancer Diagnostics is Expected to Exhibit a Positive Growth Rate over the Forecast Period

  • Cancer biomarkers are indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body in presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Such biomarkers are assayed, using in vitro diagnostic tests in non-invasively collected biofluids, like blood or serum.
  • As per the data by the International Agency for Research on Cancer, the reported cases of cancer have increased drastically among both men and women. As per 2018 data and estimates, the number of cancer cases reported is expected to rise, from 409,808 in 2018 to 466,066 by 2030. As cancer incidence is further expected to rise in the future, the demand for in vitro diagnostics for early diagnosis is expected to rise.

Competitive Landscape

BioMerieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, and Bio-Rad Laboratories Inc. are some of the major players in the market. The major companies are focusing on increasing technological advancements, in order to address customer needs, like fully automated systems, which reduce manual processes and consumables, and also provide fast and accurate results.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 47146

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Prevalence of Chronic Diseases
    • 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics
    • 4.2.3 Advanced Technologies
    • 4.2.4 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulations
    • 4.3.2 Cumbersome Reimbursement Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Test Type
    • 5.1.1 Clinical Chemistry
    • 5.1.2 Molecular Diagnostics
    • 5.1.3 Immuno Diagnostics
    • 5.1.4 Hematology
    • 5.1.5 Other Test Types
  • 5.2 By Product
    • 5.2.1 Instrument
    • 5.2.2 Reagent
    • 5.2.3 Other Products
  • 5.3 By Usability
    • 5.3.1 Disposable IVD Devices
    • 5.3.2 Reusable IVD Devices
  • 5.4 By Application
    • 5.4.1 Infectious Disease
    • 5.4.2 Diabetes
    • 5.4.3 Cancer/Oncology
    • 5.4.4 Cardiology
    • 5.4.5 Autoimmune Disease
    • 5.4.6 Nephrology
    • 5.4.7 Other Applications
  • 5.5 By End Users
    • 5.5.1 Diagnostic Laboratories
    • 5.5.2 Hospitals and Clinics
    • 5.5.3 Other End Users


  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 ARKRAY Inc.
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 BioMerieux
    • 6.1.5 Bio-Rad Laboratories Inc.
    • 6.1.6 Danaher Corporation
    • 6.1.7 QIAGEN
    • 6.1.8 Roche Diagnostics
    • 6.1.9 Siemens AG
    • 6.1.10 Thermo Fisher Scientific


Back to Top